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The phenomena of resistance and susceptibility to the transplant- 
able  tumors  of  rats  and  mice  have  been  exhaustively  studied. 
Extended observations have been  made  on the behavior of carci- 
noma grafts in immune mice.  All of the recognized methods for 
the demonstration of specific antibodies have been employed in the 
study of the body fluids of immune animals.  It maybe stated sum- 
marily that immunity to tumor growth does not correspond to any 
of the types of immunity produced by the reaction of the body to 
injections of alien cells or to infective organisms and their products. 
Moreover,  Russell  (I)  has shown that in immune mice inoculated 
cancer  tissue  fails  to  grow  because  of  the  absence  of  a  specific 
stroma  reaction  on the  part  of  the  host,  and  not  because  of  the 
presence of cytotoxic or cytolytic substances acting on the implanted 
grafts.  Or, stated differently, in immune animals implanted cancer 
cells  lose their  power  of  calling  forth  a  stroma  reaction.  He 
observed that, notwithstanding the absence of a  stroma, the tumor 
cells remained alive and proliferated for eight to ten days. 
The method of cultivating tissues  outside the body,  devised by 
Harrison  (2)  for the study of the developing nerve fiber  in  frog 
embryos, and modified by Burrows  (3)  in its application to warm- 
blooded animals,  affords  another means  for  studying the  reaction 
of immunity to cancer, one, too, in which any reactive phenomena 
may be observed in  all  stages  in  a  single specimen.  Tumor cells 
growing  in  blood  plasma  find  in  the  fibrin  network  an  artificial 
stroma,  so  that  the  influence  of  the  plasma  alone  may  be  held 
accountable if cancer cells which grow very readily in plasma from 
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normal  animals  fail  to  grow  or  are  modified  in  their  growth  in 
plasma  from  immune  animals.  In  the  present  investigation  we 
have applied this method to the study of tumor immunity, using a 
virulent  rat  sarcoma  from  Ehrlich's  laboratory.  It  may be  well, 
before describing our experiments, to  review very briefly the sub- 
ject of cancer immunity. 
Two  kinds  of  immunity  to  the  transplantable  rat  and  mouse 
tumors are recognizable, natural and artificial.  The percentage of 
naturally immune animals  (nullers)  varies with age and with dif- 
ferent varieties and  strains.  Old  animals  are,  as  a  rule, less  sus- 
ceptible than young.  Animals in which tumors have grown for a 
time  and  then undergone retrogression and  absorption  are  highly 
resistant  to  further  inoculations.  This  refractory condition  may 
be regarded as a natural resistance artificially increased through the 
absorption of tumor tissue.  Animals may be artificially immunized 
in  various  ways.  Ehrlich  (4)  showed  that  mice  inoculated  with 
large doses of a  hemorrhag{c mouse carcinoma of very low  viru- 
lence were rendered immune to more virulent carcinomata,  and  to 
a  less extent to sarcoma.  Loeb  (5)  was able to immunize rats  in 
a  similar  manner,  that  is,  by  the  inoculation  of  tumor  tissue  of 
artificially diminished resistance  (heat).  Others have shown that 
different degrees of resistance may be induced by the injectio  n  of 
suitable  quantities  of  various  homologous  tissues,  as,  embryo 
(Sch6ne  (7)),  blood  (Bashford  (6)),  liver  (Bridr6  (8)),  etc. 
Woglom  (9)  found that the subcutaneous inoculation of a  mouse's 
own spleen gave results comparable to those obtained when spleen 
tissue  from other  mice  was  used.  More  recently,  successful  im- 
munization through the use of tissues  from alien species has  been 
reported  (C. Lewin <Io), I. Levin  (II)).  Furthermore, I.  Levin 
(I I)  has  found that the autolyzed products of normal organs  are 
quite  as  efficient as the  fresh  intact cells in  the production of  im- 
munity.  Ehrlich's athreptic immunity, to  any wide application of 
which  many  objections  have  been  advanced,  constitutes  another 
kind of immunity, but since it has no direct bearing on our experi- 
ments, a discussion of it will be omitted. 
In the present study we have used six types of immune animals: 
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tions gave 80 to 9 °  per cent. of takes;  (2)  nullers from a  hooded 
variety of rats in which the percentage of takes was only 2o to 3 ° 
(racial immunity);  (3)immune  old animals whose immunity was 
probably  attributable  to  their  age;  (4)  animals  in  which  both 
sarcoma  and  carcinoma  inoculations  had  been  negative  (pan- 
immunity);  (5)  animals whose tumors  (sarcoma)  had undergone 
retrogression and absorption;  (6)  artificially immunized rats  from 
a  series of animals that had received two cubic centimeters of rat's 
blood, and had resisted subsequent sarcoma inoculations.  The per- 
centage of resistant rats in the series was 4o. 
In all, eighteen immune rats were used, and from each sufficient 
plasma was obtained for fifteen to twenty culture preparations.  We 
found that sarcoma grew readily in the plasma  from every animal 
used.  The character of the growth did not differ essentially from 
that  observed in  control specimens  in  which plasma  from normal 
and tumor-bearing animals was employed. 
ANIMAL  INOCULATIONS. 
To  test  the  viability  of  sarcomatous  tissue  cultivated  in  vitro, 
animal  inoculations  were  made.  Chart  I  shows  graphically  the 
tumors  resulting  from the  implantation  of pieces of  sarcoma that 
had  been  incubated  for  three  days  at  37 °  C.,  and  were growing 
satisfactorily.  In this  series both  the original pieces and the out- 
growths embedded in plasma were used for inoculation.  We have, 
however, obtained tumors when only the outgrowth was inoculated. 
Chart  I  is  also  designed  to  present  a  comparison  of  the  tumors 
resulting  from  the  inoculation of  pieces  of  sarcoma  cultivated  in 
plasma from normal animals and of tumors  from pieces grown in 
immune plasma.  It is seen that the percentage of takes is as high, 
and  the  rate of growth as  rapid,  in  the one as  in  the  other.  If, 
however, we compare the entire series of inoculations with sarcoma 
cultivated in vitro with a  series of inoculations with sarcoma taken 
directly from the animal bearing the tumor,  as  is  done in routine 
laboratory transplantations,  we find two differences: first,  the per- 
centage of takes is 5o as compared with 8o to 9 °  in the inoculations 
with  fresh  tissue;  and  secondly,  the  number  of  late  regressing 
tumors is about twice as great in the series from cultivated tissues. 508  Study  of  Cancer Immunity. 
The  lowered percentage  of  successful  inoculations  is  not,  in  this 
instance, necessarily an evidence of diminished virulence, since the 
pieces  used  were  at  least  ten  times  smaller  than  those  ordinarily 
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CHART  I. 
CHART  Z.  The tumors on the left resulted from the  inoculation of pieces of 
rat sarcoma cultivated three days in plasma from immune  animals.  The tumors 
on  the  right  occurred in  animals  inoculated with  sarcoma  cultivated  three  days 
in  plasma  from normal and  tumor-bearing  rats.  In  each  series  there  were fif- 
teen  rats;  those  not  developing tumors  were  not  charted.  Six  retrogressing 
tumors  are  noted,  three  in  each group.  The  first  row  of  figures  indicates the 
number  of  days  after  inoculation. Robert  A.  Lambert and Frederic  M.  Hanes.  509 
implanted.  Furthermore, the mass of plasma about the pieces of 
cultivated sarcoma was possibly an obstacle to early vascularization 
of the grafts.  In order to test this possibility, animals were inocu- 
lated with bits of fresh sarcoma embedded in plasma.  The yield of 
tumors was slightly greater  (60 per cent.)  than was obtained from 
the pieces of cultivated sarcoma.  The relatively large number of 
regressing tumors, however, can  hardly be  interpreted other than 
as an evidence of lowered virulence. 
Inoculations of  mouse sarcoma  cultivated  for  two  days  in  rat 
plasma showed also a smaller percentage of takes than was observed 
in the inoculations" with fresh tissue, but no regressing tumors have 
been noted. 
Small pieces of sarcoma placed in hanging drops of blood serum 
and incubated at  37 °  C.  were  inoculated after  twenty-four hours 
(twelve  animals),  thirty-six  hours  (eight  animals),  forty-eight 
hours  (eight  animals),  and  ninety-six  hours  (eight  animals). 
Three tumors resulted  from the twenty-four hour specimens, and 
two tumors from the thirty-six hour specimens.  The inoculations 
from the  forty-eight hour and  ninety-six hour preparations  were 
negative.  Sarcoma  cells  incubated  in  blood  serum,  then,  live  at 
least thirty-six hours.  A  larger number of inoculations, however, 
would be necessary in order to determine definitely the duration of 
life  of  sarcoma  cells  under these  conditions.  We  have  obtained 
tumors from the inoculation of pieces of sarcoma after nine days 
incubation in plasma. 
SUBCULTURES. 
We have made subcultures of specimens of sarcomagrowing in 
plasma by transferring to new medium the original piece of tissue 
or a  portion of the outgrowth.  Strictly speaking, transplantation 
of the original piece to new plasma does not constitute a subculture. 
The majority of the specimens cultivated in a single medium do not 
grow longer than five or  six  days,  but,  if  before cell  death  takes 
place  they  are  transferred  to  fresh  plasma,  active  growth  is  re- 
newed.  We have in this way carried pieces through five drops of 
plasma, making the transfer at intervals of three to five days.  In 
these subcultures, plasma  from both  normal and  immune animals 
was used, and growth was as vigorous in the one as in the other. 510  Study  of  Cancer  Immunity. 
CONCLUSIONS. 
I.  Sarcoma  cultivated  in  plasma  from  immune  animals  grows 
quite  as  vigorously  as  in  plasma  from  normal  and  tumor-bearing 
animals,  thus  affording  further  proof  of  the  absence  of  specific 
cytolytic substances  in the body fluids  of animals  immune  to trans- 
plantable  cancer. 
2.  Animals  may  be  successfully  inoculated  with  sarcoma  culti- 
vated in vitro, although, in the case of rat sarcoma, there is evidence 
of diminished virulence. 
3.  Subcultures  of  sarcoma  cultivated  in  vitro  may  be  made  by 
transferring to  fresh plasma  the original  piece  of  tissue,  or a  por- 
tion of the outgrowth.  The duration of life of sarcoma cells under 
these conditions seems dependent only on a  renewal of the medium. 
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